A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer
Objective: This phase II study aimed to assess the effectiveness of the docetaxel plus carboplatin combination in chemotherapy-na□ve Thai patients with advanced non-small-cell lung cancer (NSCLC). Material and Method: Forty patients with Eastern Cooperative Oncology Group (ECOG) performance status (...
Saved in:
Main Authors: | Sumitra Thongprasert, Sirikul Soorraritchingchai, Busayamas Chewaskulyong, Chaiyut Charoentum, Sutthirak Munprakan |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33646002331&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/61899 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
by: Chaiyut Charoentum, et al.
Published: (2018) -
Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
by: Chaiyut Charoentum, et al.
Published: (2018) -
Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
by: Charoentum C., et al.
Published: (2014) -
Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
by: Sumitra Thongprasert, et al.
Published: (2018) -
Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
by: Charoentum C., et al.
Published: (2014)